Regional Variation Of Mortality Within 1 Year After Acute Myocardial Infarction And Factors Affecting Mortality

Similar documents
Epidemiologic Characteristics of Recent Measles Outbreaks in ROK

국내소아무균성뇌막염의전국적발생양상 정해관박수경기모란이관 B3 3 [14], 1995 B3 7 [13,15], 1996 B1[13], A24 9[16], 1997 B5 Echo 30[17,18], [19] [1-4]. . - [10].

DECISION-CTO. Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion. Seung-Jung Park, MD., PhD.

Supplementary Appendix

Pharmacy Clinical Support Technician. Cardiac Sciences Program

The MAIN-COMPARE Registry

Epidemiology and Regional Distribution of Pediatric Unintentional Emergency Injury in Korea from 2010 to 2011

Supplement materials:

Executive Summary of Stroke Statistics in Korea 2018: A Report from the Epidemiology Research Council of the Korean Stroke Society

Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998

Appendix 1: Supplementary tables [posted as supplied by author]

Supplementary Online Content

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial)

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008

Validity of the Diagnosis of Acute Myocardial Infarction in Korean National Medical Health Insurance Claims Data: The Korean Heart Study (1)

Population-Based Study of the Epidemiology of Herpes Zoster in Korea

Received: 14 August 2017; Accepted: 18 October 2017; Published: 22 October 2017

Optimal Duration of Clopidogrel Therapy with DES to Reduce Late Coronary Arterial Thrombotic Event. The DES LATE Trial

Patient Information Last Name: First Name: Middle Initial: Address: City: State: Zip Code:

Coronary Artery Stenosis. Insight from MAIN-COMPARE Study

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011

Current status and strategies for hepatitis B control in Korea

Adherence to Physical Activity Among Older Adults Using a Geographic Information System: Korean National Health and Nutrition Examinations Survey IV

California Cardiovascular Consultants Medical Associates

Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension

Nationwide Cancer Incidence in Korea,

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

FMD situation & Control Strategy in Korea

Current status and strategies for the control of viral hepatitis A in Korea

Patterns of medical accidents and disputes in the orthodontic field in Korea

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.

CLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016

Stroke is the third leading cause of death in South Korea. 1

The MAIN-COMPARE Study

SUPPLEMENTAL MATERIALS

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

2017 Cardiology Survival Guide

The burden of acute myocardial infarction after a regional cardiovascular center project in Korea

Humidifier disinfectant lung injury, how do we approach the issues?

Exercise treadmill testing is frequently used in clinical practice to

Outbreaks and control of swine influenza viruses in Korea

A Study on the Strategic Vitalization Plan of Korean Integrated Medical Tourism

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Attending Physician Statement- Coronary Artery Disease / Coronary Artery Surgery

EFFECT OF ACTIVE SMOKING AND SECOND-HAND SMOKE ON ASTHMA OF YOUNG PEOPLE: COMMUNITY HEALTH SURVEY

Cancer Statistics in Korea: Incidence, Mortality and Survival in

MHSPHP Metrics Forum. Diabetes.

Changing Patterns of Primary Treatment in Korean Men with Prostate Cancer Over 10 Years: A Nationwide Population Based Study

2017 Obesity Fact Sheet

Simulation of Infectious Disease Spreading based on Agent Based Model in South Korea 1

Hyeon-Cheol Gwon, On the behalf of SMART-DATE trial investigators ACC LBCT 2018

CORONARY ARTERY DISEASE OVERVIEW

Rates and patterns of participation in cardiac rehabilitation in Victoria

The University of Mississippi School of Pharmacy

DISCOVERING THE CONFIGURATIONS OF THE FACTORS AFFECTING COMMUNITY WELL-BEING IN KOREA USING QCA METHOD

Cancer Statistics in Korea: Incidence, Mortality and Survival in 2005

Obesity in Korean Men: Results from the Fourth through Sixth Korean National Health and Nutrition Examination Surveys ( )

Prevalence and Factors Associated with the Use of Eye Care Services in South Korea: Korea National Health and Nutrition Examination Survey

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

임시형심박조율기없이시행한경피적우관동맥중재술의 안전성 : 전향적연구

Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke

APPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10

Supplementary Appendix

Supplementary Appendix

Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea

12 Lead Electrocardiogram (ECG) PFN: SOMACL17. Terminal Learning Objective. References

Seung-Woon Rha, MD, PhD FACC, FAHA, FESC, FSCAI, FAPSIC. Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.

Our Commitment to Quality and Patient Safety Core Measures

ClinicalTrials.gov Identifier: NCT Sponsor/company: Sanofi-Aventis. Date: 08/02/ 2008

BIOE 301. Lecture Fifteen

Original Article. Introduction. Korean Circulation Journal

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Errata. Basic ICD-9-CM Coding, 2006 Edition AC200505K

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

A study of the awareness of chronic liver diseases among Korean adults

Variations in Procedure Use

Prognostic significance of non-chest pain symptoms in patients with non-st-segment elevation myocardial infarction

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Patient-Centered Primary Care Scorecard Measures

Research Article. Open Access

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations

Factors Influencing Suicidal Ideation in the Elderly

Circulation and Cardiac Emergencies. Emergency Medical Response

Quality Payment Program: Cardiology Specialty Measure Set

Prevalence of fungal infections using National Health Insurance data from , South Korea

Active Surveillance of Adverse Events Following Immunization against Pandemic Influenza A (H1N1) in Korea

Supplementary Table S1: Proportion of missing values presents in the original dataset

PROMUS Element Experience In AMC

NDLS. Cardiac Conditions and Driving

Supplementary Online Content

LAMIS (Livalo in AMI Study)

Transcription:

Regional Variation Of Mortality Within 1 Year After Acute Myocardial Infarction And Factors Affecting Mortality Hyun Joo Kim 1) ; Hack-Lyoung Kim 2) ; Jin Yong Lee 3),4) ; Sang Jun Eun 5) ; Sang Hyun Cho 6) ; Sookyung Park 7) ; Yoon Kim 6) 1)Department Of Nursing, Shinsung University, Dangjin, Korea; 2)Division Of Cardiology, Department Of Internal Medicine, Seoul National University College Of Medicine, Seoul, Korea; 3)Institute Of Health Policy And Management, Medical Research Center, Seoul National University, Seoul, Korea; 4)Public Health Medical Service, Boramae Medical Center, Seoul National University College Of Medicine, Seoul, Korea; 5)Department Of Preventive Medicine, Chungnam National University School Of Medicine, Daejeon, Korea; 6)Department Of Health Policy And Management, Seoul National University College Of Medicine, Seoul, Korea; 7)Korea Health Industry Development Institute, Chungju, Korea;

What Is Acute Myocardial Infarction (AMI)? Acute myocardial infarction (AMI) is the medical name for a heart attack. Heart attacks occur when the flow of blood to the heart becomes blocked. They can cause tissue damage and can even be life-threatening. http://www.healthline.com/health/acute-myocardial-infarction#diagnosis5 2

What Are the Symptoms of AMI? While the classic symptoms of a heart attack are chest pain and shortness of breath, the symptoms can be quite varied. The most common symptoms of a heart attack include: pressure or tightness in the chest pain in the chest, back, jaw, and other areas of the upper body that lasts more than a few minutes or that goes away and comes back shortness of breath sweating nausea vomiting anxiety a cough dizziness a fast heart rate http://www.healthline.com/health/acute-myocardial-infarction#diagnosis5 3

How Is AMI Treated? 1. Percutaneous transluminal coronary angioplasty (PTCA) PTCA is small balloon attached to the catheter in order to reopen the artery, allowing blood flow to resume. 2. Coronary artery bypass graft (CABG) CABG is a surgical procedure to restore normal blood flow to an obstructed coronary artery. http://www.healthline.com/health/acute-myocardial-infarction#diagnosis5 4

Background Post-discharge management of AMI patients is very important because it is a significant impact on mortality. The mortality due to AMI could be significantly reduced if adequate follow up in the primary care setting is achieved after discharge. However, a large-scale study on this has not yet done in Korea. In addition, There is also no study of whether there are deviations according to administrative districts. 5

Objectives The purpose of this study was to determine the regional variation of mortality within 1 year after AMI and the factors affecting it. 6

Methods (1) The data used in this study was from Korean National Health Insurance Service (KNHIS), which includes electronic insurance claims data for all citizens. All medical records of patients who were admitted with AMI(I21, I21.0, I21.1, I21.2, I21.3, I21.4, I21.9 of the ICD- 10 code) as primary diagnosis in 2004 were obtained. Patients who had medical records for AMI in 2002 and 2003 were excluded. * ICD-10, International Statistical Classification of Diseases and Related Health Problems 10th Revision 7

Methods (2) There were 12,658 new AMI patients in 2004 and a total of 2,579,361 cases including 103,390 hospitalization cases and 2,475,971 outpatient cases was used for the analysis. Kaplan-Meier analysis was used to obtain 1-year mortality. Cox proportional hazards regression model was used to determine the factors affecting 1-year mortality. 8

Methods (3) Variable description Variable CCI TV TP COC MMCI MFPC MPR Description Charlson comorbidity index Total number of visits Total number of providers continuity of care Modified, modified continuity index Most frequent provider continuity Medication possession ratio 9

Methods (4) Continuity of care Continuity of care, defined as a sustained partnership between patient and clinician, is considered a core element of high-quality primary care. 10

Results 11

Administrative districts in Korea (17 districts in total) 12

Results (1) There are 8 metropolitan cities and 9 provinces in south Koera. One-year mortality of new AMI patients was 15% on the average. As a result of analyzing the age adjusted mortality rate, Busan was the highest at 22.7% and Jeonbuk was the lowest at 5.6%. There was four fold difference in age adjusted 1-year mortality between the highest region and the lowest region. 13

Table 1. One-year mortality of new AMI patients Variable Age adjusted mortality Crude rate Total 14.5 14.6 Busan 22.7 18.1 Chungnam 13.3 13.7 Gangwon 10.6 13.7 Gyeongbuk 10.4 16.5 Ulsan 10.2 10.3 Gyeonggi-do 9.8 13.3 Gyeongnam 9.3 16.3 Daegu 9.3 13.5 Chungbuk 8.9 17.3 Daejeon 8.2 15.8 Incheon 7.5 14.0 Gwangju 7.3 13.3 Seoul 6.5 14.4 Jeju 6.4 12.4 Jeonnam 6.1 12.3 Jeonbuk 5.6 12.0 14

15

Results (2) Factors affecting mortality were associated with older age and more complications. The hazard ratio (HR) was higher as the age and the CCI was higher. 16

Table 2. Factors affecting mortality (1) Variable Hazard Ratio Low 95 % HR High P-Value Under 40 years Reference Age Over 40 years - under 65 years 2.66 1.91 3.70 <.0001 Over 65 years - under 80 years 10.98 7.91 15.25 <.0001 Over 80 years 24.72 17.72 34.50 <.0001 Region Urban Reference Non-urban 1.12 1.05 1.20 0.0014 Charlson comorbidity index (CCI) 1.20 1.18 1.21 <.0001 Diabetes mellitus Hyperlipidemia No Reference Yes 1.12 1.04 1.21 0.003 No Reference Yes 0.73 0.68 0.79 <.0001 17

Results (3) The mortality was relatively low when the first medical institution was tertiary hospital and the clinic was used after discharge. Higher continuity of care (MFPC), using primary care clinics for follow up and more than 300 prescription day of essential drugs for AMI were related to lower mortality. (hazard ratio: 0.35, 0.55, 0.51) 18

Table 2. Factors affecting mortality (2) Variable Hazard Ratio Low 95 % HR High P-Value Types of medical institutions used at first hospitalization Tertiary hospital Reference General hospital 0.88 0.82 0.95 0.0005 Hospital 0.86 0.7 1.04 0.113 Clinic 2.97 1.54 5.74 0.0012 Type of medical institution for outpatient use for one year after discharge of first hospitalization Tertiary hospital Reference General hospital 0.97 0.8 1.16 0.708 Hospital 0.98 0.79 1.22 0.8581 Clinic 0.55 0.47 0.64 <.0001 Total visits (TV) 1.01 1.001 1.002 0.0002 Total number of providers (TP) 0.88 0.87 0.90 <.0001 Continuity of care (COC) MFPC* 0.35 0.30 0.40 <.0001 The day of prescription essential drugs for AMI after discharge More than 300 days Reference Less than 300 days 1.95 1.81 2.10 <.0001 *MFPC, most frequent provider continuity 19

Conclusion Patients with new AMI have high mortality within one year after discharge, but the mortality can be reduced to a maximum of about 1/6 by continuous outpatient follow up and drug prescriptions. However, Further research is needed on the factors affecting the mortality of each region. 20

Thank you! 21